Laurion Capital Management’s Vigil Neuroscience VIGL Stock Holding History

Laurion Capital Management’s Portfolio VIGL Stock Details VIGL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-10,839	Closed	-$58.4K	–	612
2023 Q3	$58.4K	Sell	10,839 -88,850	-89%	-$614K	﹤0.01%	463
2023 Q2	$937K	Sell	99,689 -30,511	-23%	-$288K	0.01%	373
2023 Q1	$1.27M	Hold	130,200	–	–	0.01%	294
2022 Q4	$1.63M	Hold	130,200	–	–	0.01%	314
2022 Q3	$1.19M	Hold	130,200	–	–	0.01%	361
2022 Q2	$336K	Buy	+130,200	New	+$514K	0.01%	362

Other funds holding VIGL

AVLSA

Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return

Northpond Ventures Bethesda, Maryland $43.7M AUM 27.27% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PBPIA

Pivotal bioVenture Partners Investment Advisor San Francisco, California $280M AUM 181.4% 1-Year Est. Return

Laurion Capital Management's VIGL Position: Q4 2023 in Review

Laurion Capital Management sold out of Vigil Neuroscience (VIGL) in Q4 2023, closing a stake of 10,839 shares — an estimated $58.4K sold.

Laurion Capital Management first reported a position in VIGL in Q2 2022 and held it in 6 quarters. The position peaked at $1.63M in Q4 2022. 46 funds tracked by Wall St. Rank hold VIGL as of Q4 2023.

Laurion Capital Management reported no remaining Vigil Neuroscience position as of Q4 2023 after selling out during the quarter.
Laurion Capital Management sold 10,839 Vigil Neuroscience shares in Q4 2023, an estimated $58.4K.
Laurion Capital Management first reported a position in Vigil Neuroscience in Q2 2022 and held it in 6 quarters.
Laurion Capital Management's Vigil Neuroscience position peaked at $1.63M in Q4 2022.
46 funds tracked by Wall St. Rank held Vigil Neuroscience as of Q4 2023.

Based on Laurion Capital Management's 13F filing for Q4 2023, filed 14 Feb 2024.